Four distinct subgroups of clear cell renal cancer identified

Using gene profiling, a recent study published in Cancer Discovery has identified¬†four distinct molecular subgroups associated with response to treatment with sunitinib or pazopanib and survival. The findings demonstrate the effects of the presence of immune cells and angiogenesis on the effectiveness of sunitinib and pazopanib against the cancer, and are important for individualised decision-making. […]

read more

Potential of microRNAs as biomarkers for renal cell carcinoma

A recent review of the knowledge about the potential clinical applications of microRNAs (miRNAs) has been published in the Central European Journal of Urology. Specific biomarkers for the early detection and monitoring of renal cell carcinoma (RCC) would enable early diagnosis of the disease. A non-invasive and sensitive biomarker would also be extremely useful for […]

read more
Showing 21 to 22 of 22 results